Initial positive first-hand experience of acute keratoconus treatment using platelet-rich serums

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Presentation of a clinical case of acute keratoconus treatment by the intracameral platelet-rich plasma administration. Clinical and morphological improvement was registered from the first postoperative day, corneal edema and bullous changes completely resolved during 3 weeks. No side effects were observed. The outcome is confirmed by anterior segment optical coherence tomography data Intracameral platelet-rich autologous plasma administration is a safe and effective method of acute keratoconus treatment.

Full Text

Restricted Access

About the authors

Kirill V. Khripun

City Multifield Hospital No. 2

Email: kirdoc@mail.ru

MD, Candidate of Medical Sciences, Ophthalmologist, Head of Microsurgery Department No. 3. City Multifield Hospital No. 2

Russian Federation, St. Petersburg

Yulia V. Kobinets

Academican I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: juliakobinets@ya.ru

Second Year Ophthalmology Resident, Department of Ophthalmology. Academican I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation

Russian Federation, St. Petersburg

Elizaveta S. Rozhdestvenskaya

City Multifield Hospital No. 2

Email: shorie48@gmail.com

Ophthalmologist, Microsurgery Department No. 3. City Multifield Hospital No. 2

Russian Federation, St. Petersburg

References

  1. Alio JL, Toprak I, Rodriguez AE. Treatment of severe keratoconus hydrops with intracameral platelet-rich plasma injection. Cornea. 2019;38(12):1595-1598. https://doi.org/10.1097/ICO.0000000000002070
  2. Слонимский Ю.Б., Слонимский А.Ю. Hydrops corneae. Дифференциальная диагностика и лечение // Вестник Оренбургского государственного университета. – 2014. – № 12. – С. 276–281. [Slonimskiy YuB, Slonimskiy AYu. Hydrops corneae. Differencial diagnosis and treatment. Vestnik of the Orenburg state university. 2014;(12):276–281. (In Russ.)]
  3. Каспаров А.А., Каспарова Е.А., Павлюк А.С. Локальная экспресс-аутоцитокинотерапия (комплекс цитокинов) в лечении вирусных и невирусных поражений глаз // Вестник офтальмологии. – 2004. – T. 120. – № 1. – С. 29–32. [Kasparov AA, Kasparova EA, Pavliuk AS. Local express-autocytocinetherapy (a complex of cytokines) in the treatment of viral and virus-free eye lesions. The Russian annals of ophthalmology. 2014;120(1): 29-32. (In Russ.)]
  4. Патент РФ на изобретение RU № 2165747 С1. Каспаров А.А., Каспарова Е.А., Павлюк А.С. Способ лечения поствоспалительной буллёзной кератопатии. [Patent RUS № 2165747 S1. Kasparov AA, Kasparova EA, Pavlyuk AS. Sposob lecheniya postvospalitel’noy bullyoznoy keratopatii. (In Russ.)] Доступно по: https://yandex.ru/patents/doc/RU2165747C1_20010427. Ссылка активна на 13.07.2020.
  5. Патент РФ на изобретение RU № 2357743 C1. Каспаров А.А., Каспарова Е.А., Павлюк А.С. Средство для лечения, способ получения средства для лечения и способ лечения отёка роговицы и других проявлений ранней буллёзной кератопатии. [Patent RUS № 2357743 S1. Kasparov AA, Kasparova EA, Pavlyuk AS. Sredstvo dlya lecheniya, sposob polucheniya sredstva dlya lecheniya i sposob lecheniya oteka rogovitsy i drugikh proyavleniy ranney bulleznoy keratopatii. (In Russ.)] Доступно по: https://patentinform.ru/inventions/reg-2357743.html. Ссылка активна на 13.07.2020.
  6. Астахов С.Ю., Рикс И.А., Папанян С.С., и др. Опыт клинического применения персонализированной клеточной терапии для лечения больных с первичной эндотелиальной дистрофией после факоэмульсификации // Офтальмологические ведомости. – 2017. – Т. 10. – № 4. – С. 6–12. [Astakhov SYu, Riks IA, Papanyan SS, et al. Experience in personalized cell therapy clinical implementation for treatment of patients with primary endothelial dystrophy after phacoemulsification. Ophthalmology journal. 2017;10(4):6-12. (In Russ.)] https://doi.org/10.17816/ OV1046-12
  7. Anitua E, Andia I, Ardanza B, et al. Autologous platelets as a source of proteins for healing and tissue regeneration. E Thromb Haemost. 2004;91(1):4-15. https://doi.org/10.1160/TH03-07-0440
  8. Anitua E, Muruzabal F, Tayebbaet A, et al. Autologous serum and plasmarich in growth factors in ophthalmology: preclinical and clinical studies. Acta Ophthalmol. 2015;93(8):605-614. https://doi.org/10.1111/aos.12710
  9. Amable PR, Carias RB, Teixeira MV, et al. Platelet-rich plasma preparation for regenerative medicine: Optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4(3):67. https://doi.org/10.1186/scrt218
  10. Lopez-Garcia JS, García-Lozano I, Rivaset L, et al. [Use of autologous serum in ophthalmic practice. (In Spanish)]. Arch Soc Esp Oftalmol. 2007;82(1):9-20. https://doi.org/10.4321/s0365-66912007000100004
  11. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology. 1999;106(10):1984-1989. https://doi.org/10.1016/S0161-6420(99)90412-8
  12. Yamada N, Yanai R, Nakamura M, et al. Role of the C domain of IGFs in synergistic promotion, with a substance P-derived peptide, of rabbit corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 2004;45(4):1125-1131. https://doi.org/10.1167/iovs.03-0626
  13. Федосеева Е.В., Ченцова Е.В., Боровкова Н.В., и др. Морфофункциональные особенности плазмы, богатой тромбоцитами, и ее применение в офтальмологии // Офтальмология. – 2018. – Т. 15. – № 4. – С. 388–393. [Fedoseeva EV, Chentsova EV, Borovkova NV, et al. Morphofunctional peculiarities of platelet rich plasma and its application in ophthalmology. Ophthalmology in Russia. 2018;15(4):388-393. (In Russ.)] https://doi.org/10.18008/1816-5095-2018-4-388-393
  14. López-Plandolit S, Morales MC, Freire V, et al. Efficacy of plasma rich in growth factors for the treatment of dry eye. Cornea. 2011;30(12):1312-1317. https://doi.org/10.1097/ICO.0b013e31820d86d6
  15. Giannaccare G, Versura P, Buzzi M, et al. Blood derived eye drops for the treatment of cornea and ocular surface diseases. Transfus Apher Sci. 2017;56(4):595-604. https://doi.org/10.1016/j.transci.2017.07.023
  16. García-Conca V, Abad-Collado M, Hueso-Abancens JR, et al. Efficacy and safety of treatment of hyposecretory dry eye with platelet-rich plasma. Acta Ophthalmol. 2019;97(2):170-178. https://doi.org/10.1111/aos.13907
  17. Alio JL, Arnalich-Montiel F, Rodriguez AE. The role of «eye platelet rich plasma» (E-Prp) for wound healing in ophthalmology. Curr Pharm Biotechnol. 2012;13(7):1257-1265. https://doi.org/10.2174/138920112800624355
  18. Lee JH, Kim MJ, Ha SW, Kim HK. Autologous platelet-rich plasma eye drops in the treatment of recurrent corneal erosions. Korean J Ophthalmol. 2016;30(2):101-107. https://doi.org/10.3341/kjo.2016.30.2.101
  19. Gehring S, Hoerauf H, Laqua H, et al. Preparation of autologous platelets for the ophthalmologic treatment of macular holes. Transfusion. 1999;39(2):144-148. https://doi.org/10.1046/j.1537-2995.1999.39299154727.x
  20. Figueroa MS, Govetto A, de Arriba-Palomero P. Short-term results of platelet-rich plasma as adjuvant to 23-G vitrectomy in the treatment of high myopic macular holes. Eur J Ophthalmol. 2016;26(5):491-496. https://doi.org/10.5301/ejo.5000729
  21. Abdalrahman O, Rodriguez AE, del Barrio JL, Alio JL. Treatment of chronic and extreme ocular hypotension following glaucoma surgery with intraocular platelet-rich plasma: a case report. Eur J Ophthalmol. 2019;29(4):9-12. https://doi.org/10.1177/1120672118803515
  22. Абугова Т.Д. Клиническая классификация первичного кератоконуса // Современная оптометрия. – 2010. – № 5. – С. 17–20. [Abugova TD. Clinical classifications of primary keratoconus. Sovremennaya optometriya. 2010;(5):17-20. (In Russ.)] https://doi.org/10.17686/sced_rusnauka_2015-179

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Vogt’s striae

Download (206KB)
Indexing metadata
3. Fig. 2. Epithelial and stromal corneal edema

Download (183KB)
Indexing metadata
4. Fig. 3. Bullous changes of the corneal epithelium

Download (247KB)
Indexing metadata
5. Fig. 4. Corneal section is thickened. Epithelial and stromal bullae

Download (497KB)
Indexing metadata
6. Fig. 5. Decrease of corneal edema (10 days after intracameral platelet-rich plasma administration)

Download (366KB)
Indexing metadata
7. Fig. 6. Thinning of the cornea at the keratoconus top , Clouding of all corneal layers in this area, no edema, no bullae (2 months after intracameral platelet-rich plasma administration)

Download (153KB)
Indexing metadata
8. Fig. 7. Change of corneal profile of “cone” pattern with thinning in the optical zone, the hyperreflective zone corresponds to the area of clouding

Download (283KB)
Indexing metadata

Copyright (c) 2020 Khripun K.V., Kobinets Y.V., Rozhdestvenskaya E.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-65574 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies